Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • EW vs GSK✓SelectedUSD · GSKEW vs GSK performance historyLatest closeAs of+1.28%11/13
Stock and ETF performance explorer

EW vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-8.2%
GSK return
+44.4%
Excess return
-52.6%
Maximum drawdown
-54.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+1.3%+0.5%+0.8%+1.2%
7D+4.9%+1.1%+3.8%+4.7%
30D+23.9%+6.3%+17.6%+22.3%
3M+15.8%+1.8%+13.9%+15.2%
6M+31.7%+1.7%+30.0%+30.7%
YTD+25.7%+6.5%+19.1%+23.1%
1Y+24.4%+9.5%+14.9%+21.1%
3Y+65.9%+65.3%+0.6%+43.9%
All-8.2%+44.4%-52.6%-20.6%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling